EUVIMEDEUVIMED entdecken
Crossref

Reverse Transcriptase Activity with CRISPR (REACTR) Assay for Rapid and User-Friendly Therapeutic Drug Monitoring in Cytomegalovirus Care

Willow A Chernoske, Maya A Singh iD, Carrie H Lin, Megan M Chang, Cosette A Craig, Albert H Park iD, Joseph E Rower, Ayokunle O Olanrewaju iD

ACS Infectious Diseases · 10.07.2026 · 12 (7) · 2277-2287

DOI: 10.1021/acsinfecdis.6c00102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 16.06.2026. Verfasst von Willow A Chernoske und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States. Hauptthemen laut MEDLINE: Drug Monitoring, Cytomegalovirus Infections, Cytomegalovirus, Ganciclovir. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Arnold and Mabel Beckman Foundation, Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringCytomegalovirus InfectionsCytomegalovirusGanciclovirAntiviral AgentsRNA-Directed DNA PolymeraseReverse Transcriptase InhibitorsHumansTandem Mass Spectrometry

Stichwörter der Autor:innen

CRISPRassaycytomegalovirusenzyme activity assayganciclovirpoint-of-caretherapeutic drug monitoring

Substanzen

GanciclovirAntiviral AgentsRNA-Directed DNA PolymeraseReverse Transcriptase Inhibitors

Autor:innen und Institutionen

  • Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Department of Mechanical Engineering, University of Washington, Seattle, Washington 98195, United States.
  • Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah 84112, United States.
  • Department of Pediatrics, University of Utah, Salt Lake City, Utah 84112, United States.
  • Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112, United States.

ORCID-Profile: Maya A Singh, Albert H Park, Ayokunle O Olanrewaju

Förderung

  • Arnold and Mabel Beckman Foundation
  • Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH)

Zitieren

APA

Chernoske, W. A., Singh, M. A., Lin, C. H., Chang, M. M., Craig, C. A., Park, A. H., Rower, J. E., & Olanrewaju, A. O. (2026). Reverse Transcriptase Activity with CRISPR (REACTR) Assay for Rapid and User-Friendly Therapeutic Drug Monitoring in Cytomegalovirus Care. ACS Infectious Diseases, 12(7), 2277-2287. https://doi.org/10.1021/acsinfecdis.6c00102

Vancouver

Chernoske WA, Singh MA, Lin CH, Chang MM, Craig CA, Park AH, et al. Reverse Transcriptase Activity with CRISPR (REACTR) Assay for Rapid and User-Friendly Therapeutic Drug Monitoring in Cytomegalovirus Care. ACS Infectious Diseases. 2026;12(7):2277-2287. doi:10.1021/acsinfecdis.6c00102

BibTeX
@article{Chernoske2026,
  author = {Chernoske, Willow A and Singh, Maya A and Lin, Carrie H and Chang, Megan M and Craig, Cosette A and Park, Albert H and Rower, Joseph E and Olanrewaju, Ayokunle O},
  title = {Reverse Transcriptase Activity with CRISPR (REACTR) Assay for Rapid and User-Friendly Therapeutic Drug Monitoring in Cytomegalovirus Care},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {2277--2287},
  doi = {10.1021/acsinfecdis.6c00102}
}
Kostenlos starten →